Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.070
0.00 (0.00%)
At close: Aug 1, 2025, 4:00 PM
1.090
+0.020 (1.87%)
After-hours: Aug 1, 2025, 7:45 PM EDT
Heartland Financial USA Employees
Lexicon Pharmaceuticals had 103 employees as of December 31, 2024. The number of employees decreased by 182 or -63.86% compared to the previous year.
Employees
103
Change (1Y)
-182
Growth (1Y)
-63.86%
Revenue / Employee
$303,039
Profits / Employee
-$1,721,369
Market Cap
388.60M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103 | -182 | -63.86% |
Dec 31, 2023 | 285 | 150 | 111.11% |
Dec 31, 2022 | 135 | 48 | 55.17% |
Dec 31, 2021 | 87 | 9 | 11.54% |
Dec 31, 2020 | 78 | -106 | -57.61% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LXRX News
- 2 days ago - Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewsWire
- 10 days ago - Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 - GlobeNewsWire
- 15 days ago - Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025) - GlobeNewsWire
- 5 weeks ago - Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 6 weeks ago - Lexicon to Present Data at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - SONATA-HCM Study Design Presented at Heart Failure 2025, the Annual Congress of the Heart Failure Association of the European Society of Cardiology - GlobeNewsWire
- 2 months ago - Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2025 Earnings Call Transcript - Seeking Alpha